Skip to content

Hemidiaphragmatic Paralysis With Diluted Continuous Interscalene Plexus Infusions

Incidence of Hemidiaphragmatic Paralysis Using 0.04% Levobupivacaine for Continuous Interscalene Brachial Plexus Blocks in Arthroscopic Shoulder Surgeries

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03592056
Enrollment
30
Registered
2018-07-19
Start date
2018-08-10
Completion date
2019-07-23
Last updated
2020-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Pain, Diaphragmatic Paralysis, Postoperative Pain, Shoulder Injury, Shoulder Pain

Keywords

hemidiaphragmatic paralysis, continuous plexus block, interscalene plexus block, diluted local anesthetic infusion, ambulatory regional analgesia, ambulatory continuous nerve block, continuous local anesthetic infusion

Brief summary

Interscalene brachial plexus block (ISB) constitutes the analgesic criterion standard for shoulder surgery. However, it is associated with a high incidence of hemidiaphragmatic paralysis (HDP) that may not be tolerated by patients with chronic pulmonary disease. Continuous ISBs have not avoided this complication with the reported and regularly used local anesthetic dilutions (i.e. 0.125% bupivacaine, 0.25% ropivacaine, etc). This observational study will register the incidence of HDP in continuous interscalene block (CISB) using a very diluted solution of levobupivacaine (0.04%) in patients undergoing arthroscopic shoulder surgery. The main objective of this study is to determine the frequency of HDP the first postoperative day before patient discharge(POD).

Interventions

None listed

Sponsors

Clinica las Condes, Chile
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* age between 18 and 80 years * American Society of Anesthesiologists classification 1-3 * body mass index between 20 and 35

Exclusion criteria

* adults who are unable to give their own consent * pre-existing neuropathy (assessed by history and physical examination) * coagulopathy (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. platelets ≤ 100, International Normalized Ratio ≥ 1.4 or prothrombin time ≥ 50) * renal failure (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. creatinine ≥ 100) * hepatic failure (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. transaminases ≥ 100) * allergy to local anesthetics (LAs) * pregnancy * prior surgery in the ipsilateral neck region * chronic pain conditions

Design outcomes

Primary

MeasureTime frameDescription
Hemidiaphragmatic paralysis before discharge24 hours after surgeryDefined as less than 25% of basal diaphragm excursion evaluated with ultrasonography

Secondary

MeasureTime frameDescription
Amount of local anesthetic (LA) boluses used before discharge.24 hours after surgeryboluses of LA administered by the patient controlled infusor in adidiotn to a basal rate.
Level of static postoperative pain at 30 minutes of arrival to PACU30 minutes after arrival to PACUlevel of pain at rest referred by the patient using a numeric rating scale from 0 to 10
Level of static postoperative pain 1 hour after arrival to PACU60 minutes after arrivallevel of pain at rest referred by the patient using a numeric rating scale from 0 to 10
Level of static postoperative pain 3 hour after arrival to PACU3 hours after arrival to PACUlevel of pain at rest referred by the patient using a numeric rating scale from 0 to 10
level of static pain 6 hours after arrival to PACU6 hours after arrival to PACUlevel of pain at rest referred by the patient using a numeric rating scale from 0 to 10
Level of static pain 12 hours after arrival to PACU12 hour after arrival to PACULevel of pain at rest referred by the patient using a numeric rating scale from 0 to 10
Level of static pain before discharge24 hours post surgeryLevel of pain at rest referred by the patient using a numeric rating scale from 0 to 10
Level of static pain during first day after the day of discharge48 hours after surgeryLevel of pain at rest referred by the patient using a numeric rating scale from 0 to 10
Hemidiaphragmatic paralysis after surgery30 minutes after arrival to post anesthetic care unit (PACU)Defined as less than 25% of basal diaphragm excursion evaluated with ultrasonography
intraoperative morphine equivalent consumptionintraoperative periodtotal amount of morphine equivalent opioid requirement in milligrams
postoperative morphine equivalent consumption24 hours after surgerytotal amount of morphine equivalent opioid requirement in milligrams
sensory block in PACU30 minutes after arrival to PACUloss of sensation to cold in lateral deltoid area
Motor block in PACU30 minutes after arrival to PACUparesia or paralysis in operated side, shoulder, arm, forearm or hand
sensory block previous to discharge24 hours after surgeryloss of sensation to cold in lateral deltoid area
motor block previous to discharge24 hours after surgeryparesia or paralysis in operated side shoulder, arm, forearm or hand
Incidence of side effects before discharge24 hours after surgerypresence of side effects (vascular puncture, Horner syndrome, hoarseness, LA systemic toxicity, catheter dislodgement, catheter insertion site leak), related with the block.
incidence of side effects after discharge with ambulatory continuous ISB.24 to 72 hours after surgerypresence of side effects (vascular puncture, Horner syndrome, hoarseness, LA systemic toxicity, catheter dislodgement, catheter insertion site leak), related with the block.
Level of static pain during second day after the day of discharge72 hours after surgeryLevel of pain at rest referred by the patient using a numeric rating scale from 0 to 10

Countries

Chile

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026